This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grande, D. A.
Right arrow Articles by Dines, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grande, D. A.
Right arrow Articles by Dines, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 85:111-116 (2003)
© 2003 The Journal of Bone and Joint Surgery, Inc.


Scientific Article

Stem Cells as Platforms for Delivery of Genes to Enhance Cartilage Repair

Daniel A. Grande, PhD, James Mason, PhD, Evan Light and David Dines, MD

Daniel A. Grande, PhD
North Shore/Long Island Jewish Research Institute, 350 Community Drive, Manhasset, NY 11030. E-mail address: dgrande{at}nshs.edu

In support of their research or preparation of this manuscript, one or more of the authors received grants or outside funding from the North Shore/LIJ Orthopaedic Surgery Department and the North Shore/LIJ Research Institute. None of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: The long-held axiom put forth by Hunter in 1743, that cartilage once injured is incapable of healing, has been challenged by the technique of autologous chondrocyte transplantation. This conceptual change in the way in which orthopaedists are approaching the problem of cartilage repair has spawned a myriad of new and innovative treatment modalities. This review will focus on the new techniques and directions that our facility and other investigators are exploring to restore functional articular cartilage.

Methods: To show the usefulness and effectiveness of local tissue-engineered gene therapy, we transduced periosteal stem cells known to have osteochondral potential with either bone morphogenetic protein-7 (BMP-7) or sonic hedgehog (Shh) gene. These cells were cultured to increase the number of cells and then were seeded onto bioresorbable polymer scaffolds. Full-thickness osteochondral defects were created in the mid-trochlear region of eighty New Zealand White rabbits, and the implants containing the transduced cells were placed in the defects. Animals were killed at six, eight, twelve, and twenty-six weeks postoperatively and were examined macroscopically and histologically.

Results: Periosteal-derived cambium-layer cells proliferated rapidly and were easily used for transfection of both the bone morphogenic protein-7 (BMP-7) and sonic hedgehog (Shh) genes. The control defects became filled with a mixture of fibrous and fibrocartilaginous tissue. The addition of either the BMP-7 or the Shh gene significantly enhanced the quality of the repair tissue, resulting in a much smoother surface and more hyaline-appearing cartilage. There was, however, a noticeable difference in the persistence of the cartilage phase between the group that received the Shh gene and the group that received the BMP-7 gene, with the subchondral compartment in the latter group seeming to remodel with bone much faster.

Conclusion and Clinical Relevance: The results of these experiments clearly demonstrate the utility of tissue-engineering strategies in which gene therapy is used to locally influence the repair environment. It is interesting to note the relative differences in the two different gene responses with regard to skeletal development and the repair process. These differences could be related to the genes' temporal patterns in skeletal development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
D Mrugala, C Bony, N Neves, L Caillot, S Fabre, D Moukoko, C Jorgensen, and D Noel
Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model
Ann Rheum Dis, March 1, 2008; 67(3): 288 - 295.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. Scharstuhl, B. Schewe, K. Benz, C. Gaissmaier, H.-J. Buhring, and R. Stoop
Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis Etiology
Stem Cells, December 1, 2007; 25(12): 3244 - 3251.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
N. Yoganandan, F. A. Pintar, B. D. Stemper, C. E. Wolfla, B. S. Shender, and G. Paskoff
Level-Dependent Coronal and Axial Moment-Rotation Corridors of Degeneration-Free Cervical Spines in Lateral Flexion
J. Bone Joint Surg. Am., May 1, 2007; 89(5): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. J. Wood, M. A. Malek, F. J. Frassica, J. A. Polder, A. K. Mohan, E. T. Bloom, M. M. Braun, and T. R. Cote
Autologous Cultured Chondrocytes: Adverse Events Reported to the United States Food and Drug Administration
J. Bone Joint Surg. Am., March 1, 2006; 88(3): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
C. H. Evans, S. C. Ghivizzani, J. H. Herndon, and P. D. Robbins
Gene Therapy for the Treatment of Musculoskeletal Diseases
J. Am. Acad. Ortho. Surg., July 1, 2005; 13(4): 230 - 242.
[Abstract] [Full Text] [PDF]